Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

SELL
$463.67 - $597.16 $2.82 Million - $3.64 Million
-6,091 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$524.57 - $735.42 $985,667 - $1.38 Million
1,879 Added 44.61%
6,091 $3.43 Million
Q4 2021

Jan 24, 2022

BUY
$708.84 - $794.68 $377,811 - $423,564
533 Added 14.49%
4,212 $3.18 Million
Q3 2021

Oct 22, 2021

SELL
$657.71 - $825.77 $277,553 - $348,474
-422 Reduced 10.29%
3,679 $2.74 Million
Q2 2021

Jul 26, 2021

SELL
$576.64 - $649.04 $525,319 - $591,275
-911 Reduced 18.18%
4,101 $2.64 Million
Q1 2021

Apr 23, 2021

SELL
$547.01 - $662.35 $89,162 - $107,963
-163 Reduced 3.15%
5,012 $2.86 Million
Q4 2020

Jan 25, 2021

BUY
$510.68 - $643.45 $108,774 - $137,054
213 Added 4.29%
5,175 $3.02 Million
Q3 2020

Dec 14, 2020

SELL
$454.43 - $535.6 $155,869 - $183,710
-343 Reduced 6.47%
4,962 $2.56 Million
Q2 2020

Jul 23, 2020

BUY
$334.87 - $493.06 $975,811 - $1.44 Million
2,914 Added 121.87%
5,305 $2.4 Million
Q1 2020

Apr 23, 2020

SELL
$320.01 - $409.07 $309,769 - $395,979
-968 Reduced 28.82%
2,391 $838,000
Q4 2019

Jan 24, 2020

BUY
$319.73 - $374.2 $639,460 - $748,400
2,000 Added 147.17%
3,359 $1.24 Million
Q3 2019

Oct 21, 2019

BUY
$304.55 - $345.24 $76,137 - $86,310
250 Added 22.54%
1,359 $452,000
Q2 2019

Jul 25, 2019

SELL
$286.93 - $312.59 $36,153 - $39,386
-126 Reduced 10.2%
1,109 $346,000
Q1 2019

Apr 19, 2019

SELL
$224.3 - $317.41 $128,972 - $182,510
-575 Reduced 31.77%
1,235 $377,000
Q4 2018

Jan 23, 2019

BUY
$220.1 - $309.0 $2,861 - $4,017
13 Added 0.72%
1,810 $420,000
Q3 2018

Oct 19, 2018

BUY
$289.28 - $326.15 $195,842 - $220,803
677 Added 60.45%
1,797 $562,000
Q2 2018

Aug 06, 2018

BUY
$244.1 - $303.88 $273,392 - $340,345
1,120 New
1,120 $323,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.38B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.